G-protein involvement in matrix-mediated motility and invasion of high and low experimental metastatic B16 melanoma clones

B. R. Lester, J. B. McCarthy, Z. Sun, R. S. Smith, L. T. Furcht, Allen M. Spiegel

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Membranes from a B16 murine melanoma clone of high experimental metastatic capacity show increased amounts of pertussis toxin (PT) substrate when compared to a low metastatic counterpart. Using specific antibodies, we identified G12 as the PT-sensitive G-protein uniquely abundant in highly metastatic cells. ADP ribosylation of a G-protein α subunit by PT decreased both the migration of tumor cells through Matrigel (Collaborative Research, Bedford, MA) and the fibronectin-, laminin-, and collagen type IV-mediated motility of a high metastatic clone. Treatment of cells from a low metastatic clone with PT did not alter either the relatively low invasive capacity or lower motility of these cells. While cholera toxin treatment of cells resulted in decreased invasion and motility of both high and low metastatic clones, there were significant qualitative and quantitative differences, when compared to the PT effects, which indicated that the two toxins were acting on different second messenger systems. PT treatment of B16 clones of high or low experimental metastatic capacity does not result in any alteration in cellular cyclic AMP accumulation suggesting that the PT substrate is not linked with the adenylyl cyclase enzyme complex. The data suggest that a PT-sensitive G-protein, possibly G12, regulates second messenger pathways that contribute to the metastatic capacity of B16 melanoma cells.

Original languageEnglish (US)
Pages (from-to)5940-5948
Number of pages9
JournalCancer Research
Volume49
Issue number21
StatePublished - 1989
Externally publishedYes

Fingerprint

Experimental Melanomas
Pertussis Toxin
GTP-Binding Proteins
Clone Cells
Second Messenger Systems
Cell Movement
Collagen Type IV
Cholera Toxin
Protein Subunits
Laminin
Fibronectins
Adenylyl Cyclases
Cyclic AMP
Adenosine Diphosphate
Membranes
Antibodies
Enzymes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

G-protein involvement in matrix-mediated motility and invasion of high and low experimental metastatic B16 melanoma clones. / Lester, B. R.; McCarthy, J. B.; Sun, Z.; Smith, R. S.; Furcht, L. T.; Spiegel, Allen M.

In: Cancer Research, Vol. 49, No. 21, 1989, p. 5940-5948.

Research output: Contribution to journalArticle

Lester, B. R. ; McCarthy, J. B. ; Sun, Z. ; Smith, R. S. ; Furcht, L. T. ; Spiegel, Allen M. / G-protein involvement in matrix-mediated motility and invasion of high and low experimental metastatic B16 melanoma clones. In: Cancer Research. 1989 ; Vol. 49, No. 21. pp. 5940-5948.
@article{e4ca51b335624438bfa89981ab9d2cac,
title = "G-protein involvement in matrix-mediated motility and invasion of high and low experimental metastatic B16 melanoma clones",
abstract = "Membranes from a B16 murine melanoma clone of high experimental metastatic capacity show increased amounts of pertussis toxin (PT) substrate when compared to a low metastatic counterpart. Using specific antibodies, we identified G12 as the PT-sensitive G-protein uniquely abundant in highly metastatic cells. ADP ribosylation of a G-protein α subunit by PT decreased both the migration of tumor cells through Matrigel (Collaborative Research, Bedford, MA) and the fibronectin-, laminin-, and collagen type IV-mediated motility of a high metastatic clone. Treatment of cells from a low metastatic clone with PT did not alter either the relatively low invasive capacity or lower motility of these cells. While cholera toxin treatment of cells resulted in decreased invasion and motility of both high and low metastatic clones, there were significant qualitative and quantitative differences, when compared to the PT effects, which indicated that the two toxins were acting on different second messenger systems. PT treatment of B16 clones of high or low experimental metastatic capacity does not result in any alteration in cellular cyclic AMP accumulation suggesting that the PT substrate is not linked with the adenylyl cyclase enzyme complex. The data suggest that a PT-sensitive G-protein, possibly G12, regulates second messenger pathways that contribute to the metastatic capacity of B16 melanoma cells.",
author = "Lester, {B. R.} and McCarthy, {J. B.} and Z. Sun and Smith, {R. S.} and Furcht, {L. T.} and Spiegel, {Allen M.}",
year = "1989",
language = "English (US)",
volume = "49",
pages = "5940--5948",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "21",

}

TY - JOUR

T1 - G-protein involvement in matrix-mediated motility and invasion of high and low experimental metastatic B16 melanoma clones

AU - Lester, B. R.

AU - McCarthy, J. B.

AU - Sun, Z.

AU - Smith, R. S.

AU - Furcht, L. T.

AU - Spiegel, Allen M.

PY - 1989

Y1 - 1989

N2 - Membranes from a B16 murine melanoma clone of high experimental metastatic capacity show increased amounts of pertussis toxin (PT) substrate when compared to a low metastatic counterpart. Using specific antibodies, we identified G12 as the PT-sensitive G-protein uniquely abundant in highly metastatic cells. ADP ribosylation of a G-protein α subunit by PT decreased both the migration of tumor cells through Matrigel (Collaborative Research, Bedford, MA) and the fibronectin-, laminin-, and collagen type IV-mediated motility of a high metastatic clone. Treatment of cells from a low metastatic clone with PT did not alter either the relatively low invasive capacity or lower motility of these cells. While cholera toxin treatment of cells resulted in decreased invasion and motility of both high and low metastatic clones, there were significant qualitative and quantitative differences, when compared to the PT effects, which indicated that the two toxins were acting on different second messenger systems. PT treatment of B16 clones of high or low experimental metastatic capacity does not result in any alteration in cellular cyclic AMP accumulation suggesting that the PT substrate is not linked with the adenylyl cyclase enzyme complex. The data suggest that a PT-sensitive G-protein, possibly G12, regulates second messenger pathways that contribute to the metastatic capacity of B16 melanoma cells.

AB - Membranes from a B16 murine melanoma clone of high experimental metastatic capacity show increased amounts of pertussis toxin (PT) substrate when compared to a low metastatic counterpart. Using specific antibodies, we identified G12 as the PT-sensitive G-protein uniquely abundant in highly metastatic cells. ADP ribosylation of a G-protein α subunit by PT decreased both the migration of tumor cells through Matrigel (Collaborative Research, Bedford, MA) and the fibronectin-, laminin-, and collagen type IV-mediated motility of a high metastatic clone. Treatment of cells from a low metastatic clone with PT did not alter either the relatively low invasive capacity or lower motility of these cells. While cholera toxin treatment of cells resulted in decreased invasion and motility of both high and low metastatic clones, there were significant qualitative and quantitative differences, when compared to the PT effects, which indicated that the two toxins were acting on different second messenger systems. PT treatment of B16 clones of high or low experimental metastatic capacity does not result in any alteration in cellular cyclic AMP accumulation suggesting that the PT substrate is not linked with the adenylyl cyclase enzyme complex. The data suggest that a PT-sensitive G-protein, possibly G12, regulates second messenger pathways that contribute to the metastatic capacity of B16 melanoma cells.

UR - http://www.scopus.com/inward/record.url?scp=0024443222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024443222&partnerID=8YFLogxK

M3 - Article

C2 - 2477150

AN - SCOPUS:0024443222

VL - 49

SP - 5940

EP - 5948

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 21

ER -